A/s Genmab, 10% Owner at Merus N.V. (MRUS), bought 815,444 shares at $97.00 ($79.1M) on 2025-12-22, disclosed to the SEC on 2025-12-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $97.00 | 15,710 | $1.5M | 1.9% |
| 2 | $97.00 | 561,042 | $54.4M | 68.8% |
| 3 | $97.00 | 96,082 | $9.3M | 11.8% |
| 4 | $97.00 | 142,610 | $13.8M | 17.5% |
| Total | $97.00 avg | 815,444 | $79.1M | 100% |
| Filing → |
| MRUS | BUY | 2025-12-18 | $26.3M | — | Filing → |